Editorial: Diabetic kidney disease: routes to drug development, pharmacology and underlying molecular mechanisms

Category

Published in:

Frontiers in Pharmacology  
Vol. 14 (08.08.2023)

Volume:

14

Date Issued:

08.08.2023

DOI:

10.3389/fphar.2023.1252315

Language:

English

Type of Resource:

Text

Keywords:

diabetic kidney disease; sodium-glucose cotransporter-2 (SGLT2) inhibitors; dipeptidyl peptidase-4 (DPP4 or CD26) inhibitors; N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP); sirtuin (SIRT)3; mitoquinone (MitoQ); kidney fibrosis; mitophagy

Subject of DNB:

610 Medical sciences Medicine